1. The lipoxin A4 agonist BML-111 attenuates acute hepatic dysfunction induced by cecal ligation and puncture in rats
   Ghada S. El-Tanbouly et al, 2017, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. BML-111 Reduces Neuroinflammation and Cognitive Impairment in Mice With Sepsis via the SIRT1/NF-κB Signaling Pathway
   Shangwen Pan et al, 2018, Frontiers in Cellular Neuroscience CrossRef
3. Dietary supplementation with polysaccharides from Ziziphus Jujuba cv. Pozao intervenes in immune response via regulating peripheral immunity and intestinal barrier function in cyclophosphamide-induced mice
   Xue Han et al, 2020, Food & Function CrossRef
4. BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats
   Dan Yan et al, 2016, International Journal of Molecular Sciences CrossRef
5. Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generation
   Qiong Cheng et al, 2016, International Immunopharmacology CrossRef
6. Gadolinium chloride pre‑treatment reduces the inflammatory response and preserves intestinal barrier function in a rat model of sepsis
   Yan Zhao et al, 2021, Experimental and Therapeutic Medicine CrossRef
7. DETERMINATION OF GUT BACTERIAL METABOLITES IN RADIATION EXPOSED MICE
   Yamato Sakamoto et al, 2019, Radiation Protection Dosimetry CrossRef
8. BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats
   Quandong Hu et al, 2017, Prostaglandins & Other Lipid Mediators CrossRef
9. Effects of imipenem combined with low‑dose cyclophosphamide on the intestinal barrier in septic rats
   Peng Guo et al, 2018, Experimental and Therapeutic Medicine CrossRef
10. Pro-resolution of Inflammation: New Hints to Manage Sepsis?
    Yongjian Liu et al, 2019, Severe Trauma and Sepsis CrossRef
11. BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system
    Qiong-Feng Chen et al, 2019, Prostaglandins & Other Lipid Mediators CrossRef
12. PTX3 Protects Intestinal Mucosal Barrier Damage in Sepsis Through Toll-Like Receptor Signaling Pathway
    Jian Li et al, 2022, Inflammation CrossRef
13. Pro-Resolving Molecules—New Approaches to Treat Sepsis?
    Christa Buechler et al, 2017, International Journal of Molecular Sciences CrossRef
14. Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease
    Daniele Corridoni et al, 2018, Frontiers in Medicine CrossRef